Microbioma, salud y enfermedad: probióticos, prebióticos y simbióticos
Palabras clave:
Microbioma, salud y enfermedad, probióticos, prebióticos, simbióticos
Descargas
Los datos de descargas todavía no están disponibles.
Referencias bibliográficas
1. Reid G. Probiotics: Definition, scope and mechanisms of action. Best Pract Res Clin Gastroenterol. 2016;30:17-25.
2. Jiménez E, Marín ML, Martín R, Odriozola JM, Olivares M, Xaus J, et al. Is meconium from healthy newborns actually sterile? Res Microbiol. 2008;159:187-93.
https://doi.org/10.1016/j.resmic.2007.12.007
3. Azad MB, Konya T, Maughan H, Guttman DS, Field CJ, Chari RS, et al. Gut microbiota of healthy Canadian infants: Profiles by mode of delivery and infant diet at 4 months. CMAJ. 2013;185:385-94. https://doi.org/10.1503/cmaj.121189
4. Haro C, Rangel-Zúñiga OA, Alcalá-Díaz JF, Gómez-Delgado F, Pérez-Martínez P, Delgado-Lista J, et al. Intestinal microbiota is influenced by gender and body mass index. PLoS One. 2016;11:e0154090. https://doi.org/10.1371/journal.pone.0154090
5. Kuleshov V, Jiang C, Zhou W, Jahanbani F, Batzoglou S, Snyder M. Synthetic long-read sequencing reveals intraspecies diversity in the human microbiome. Nat
Biotechnol. 2016;34:64-9. https://doi.org/10.1038/nbt.3416
6. Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375:2369-79. https://doi.org/10.1056/NEJMra1600266
7. Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016;165:111-24. https://doi.org/10.1016/j.cell.2016.02.011
8. Ubeda C, Pamer EG. Antibiotics, microbiota, and immune defense. Trends Immunol. 2012;33:459-66. https://doi.org/10.1016/j.it.2012.05.003621
9. Edwards CJ. Commensal gut bacteria and the etiopathogenesis of rheumatoid arthritis. J Rheumatol. 2008;35:1477-9.
10. Haldar P Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178:218-24. https://doi.org/10.1164/rccm.200711-1754OC
11. Fahy JV. Type 2 inflamation in asthma -present in most, absent in many. Nat Rev Immunol. 2015;15: 57-65. https://doi.org/10.1038/nri3786
12. Ford AC, Spiegel BM, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: Systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009;7:1279-86. https://doi.org/10.1016/j.cgh.2009.06.031
13. Sachdev AH, Pimentel M. Antibiotics for irritable bowel syndrome: Rationale and current evidence. Curr Gastroenterol Rep. 2012;14:439-45. https://doi.org/10.1007/s11894-012-0284-2
14. Bultman SJ. Emerging roles of the microbiome in cancer. Carcinogenesis. 2014;35:249-55. https://doi.org/10.1093/carcin/bgt392
15. Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170:548-63.e16. https://doi.org/10.1016/j.cell.2017.07.008
16. Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, Mishra A, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov. 2018;8:403-16. https://doi.org/10.1158/2159-8290.CD-17-1134
17. Mitsuhashi K, Nosho K, Sukawa Y, Matsunaga Y, Ito M, Kurihara H, et al. Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget. . 2015;6:7209-20. https://doi.org/10.18632/oncotarget.3109
18. Liu Y, Lin Z, Lin Y, Chen Y, Peng XE, He F, et al. Streptococcus and prevotella are associated with the prognosis of oesophageal squamous cell carcinoma. J Med
Microbiol. 2018;67:1058-68. https://doi.org/10.1099/jmm.0.000754
19. Cohen RJ, Shannon BA, McNeal JE, Shannon T, Garrett KL. Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: A possible link to cancer evolution? J Urol. 2005;173:1969-74. https://doi.org/10.1097/01.ju.0000158161.15277.78
20. Shen NT, Maw A, Tmanova LL, Pino A, Ancy K, Crawford CV, et al. Timely use of probiotics in hospitalized adults prevents clostridium difficile infection: A systematic review with metaregression analysis. Gastroenterology. 2017;152:1889-900.e9. https://doi.org/10.1053/j.gastro.2017.02.003
21. Khalesi S, Sun J, Buys N, Jayasinghe R. Effect of probiotics on blood pressure: A systematic review and meta-analysis of randomized, controlled trials. Hypertension. 2014;64:897-903. https://doi.org/10.1161/HYPERTENSIONAHA.114.03469
22. Joyner PM, Liu J, Zhang Z, Merritt J, Qi F, Cichewicz RH. Mutanobactin A from the human oral pathogen Streptococcus mutans is a cross-kingdom regulator of the yeast-mycelium transition. Org Biomol Chem. 2010;8:5486-9. https://doi.org/10.1039/c0ob00579g
23. Didari T, Solki S, Mozaffari S, Nikfar S, Abdollahi M. A systematic review of the safety of probiotics. Expert Opin Drug Saf. 2014;13:227-39. https://doi.org/10.1517/14740338.2014.872627
24. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr. 1995;125:1401-12. https://doi.org/10.1093/jn/125.6.1401
25. Markowiak P, Śliżewska K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients. 2017;9(pii):E1021. https://doi.org/10.3390/nu9091021
26. Food and Drug Administration. Investigational new drug applications (IND) — Determining whether human research studies can be conducted without an IND. Bethesda: Food and Drug Administration; 2013.
27. Hojsak I, Fabiano V, Pop TL, Goulet O, Zuccotti GV, Çokuğraş FC, et al. Guidance on the use of probiotics in clinical practice in children with selected clinical conditions and in specific vulnerable groups. Acta Paediatr. 2018;107:927-37. https://doi.org/10.1111/apa.14270
2. Jiménez E, Marín ML, Martín R, Odriozola JM, Olivares M, Xaus J, et al. Is meconium from healthy newborns actually sterile? Res Microbiol. 2008;159:187-93.
https://doi.org/10.1016/j.resmic.2007.12.007
3. Azad MB, Konya T, Maughan H, Guttman DS, Field CJ, Chari RS, et al. Gut microbiota of healthy Canadian infants: Profiles by mode of delivery and infant diet at 4 months. CMAJ. 2013;185:385-94. https://doi.org/10.1503/cmaj.121189
4. Haro C, Rangel-Zúñiga OA, Alcalá-Díaz JF, Gómez-Delgado F, Pérez-Martínez P, Delgado-Lista J, et al. Intestinal microbiota is influenced by gender and body mass index. PLoS One. 2016;11:e0154090. https://doi.org/10.1371/journal.pone.0154090
5. Kuleshov V, Jiang C, Zhou W, Jahanbani F, Batzoglou S, Snyder M. Synthetic long-read sequencing reveals intraspecies diversity in the human microbiome. Nat
Biotechnol. 2016;34:64-9. https://doi.org/10.1038/nbt.3416
6. Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375:2369-79. https://doi.org/10.1056/NEJMra1600266
7. Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016;165:111-24. https://doi.org/10.1016/j.cell.2016.02.011
8. Ubeda C, Pamer EG. Antibiotics, microbiota, and immune defense. Trends Immunol. 2012;33:459-66. https://doi.org/10.1016/j.it.2012.05.003621
9. Edwards CJ. Commensal gut bacteria and the etiopathogenesis of rheumatoid arthritis. J Rheumatol. 2008;35:1477-9.
10. Haldar P Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178:218-24. https://doi.org/10.1164/rccm.200711-1754OC
11. Fahy JV. Type 2 inflamation in asthma -present in most, absent in many. Nat Rev Immunol. 2015;15: 57-65. https://doi.org/10.1038/nri3786
12. Ford AC, Spiegel BM, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: Systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009;7:1279-86. https://doi.org/10.1016/j.cgh.2009.06.031
13. Sachdev AH, Pimentel M. Antibiotics for irritable bowel syndrome: Rationale and current evidence. Curr Gastroenterol Rep. 2012;14:439-45. https://doi.org/10.1007/s11894-012-0284-2
14. Bultman SJ. Emerging roles of the microbiome in cancer. Carcinogenesis. 2014;35:249-55. https://doi.org/10.1093/carcin/bgt392
15. Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170:548-63.e16. https://doi.org/10.1016/j.cell.2017.07.008
16. Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, Mishra A, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov. 2018;8:403-16. https://doi.org/10.1158/2159-8290.CD-17-1134
17. Mitsuhashi K, Nosho K, Sukawa Y, Matsunaga Y, Ito M, Kurihara H, et al. Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget. . 2015;6:7209-20. https://doi.org/10.18632/oncotarget.3109
18. Liu Y, Lin Z, Lin Y, Chen Y, Peng XE, He F, et al. Streptococcus and prevotella are associated with the prognosis of oesophageal squamous cell carcinoma. J Med
Microbiol. 2018;67:1058-68. https://doi.org/10.1099/jmm.0.000754
19. Cohen RJ, Shannon BA, McNeal JE, Shannon T, Garrett KL. Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: A possible link to cancer evolution? J Urol. 2005;173:1969-74. https://doi.org/10.1097/01.ju.0000158161.15277.78
20. Shen NT, Maw A, Tmanova LL, Pino A, Ancy K, Crawford CV, et al. Timely use of probiotics in hospitalized adults prevents clostridium difficile infection: A systematic review with metaregression analysis. Gastroenterology. 2017;152:1889-900.e9. https://doi.org/10.1053/j.gastro.2017.02.003
21. Khalesi S, Sun J, Buys N, Jayasinghe R. Effect of probiotics on blood pressure: A systematic review and meta-analysis of randomized, controlled trials. Hypertension. 2014;64:897-903. https://doi.org/10.1161/HYPERTENSIONAHA.114.03469
22. Joyner PM, Liu J, Zhang Z, Merritt J, Qi F, Cichewicz RH. Mutanobactin A from the human oral pathogen Streptococcus mutans is a cross-kingdom regulator of the yeast-mycelium transition. Org Biomol Chem. 2010;8:5486-9. https://doi.org/10.1039/c0ob00579g
23. Didari T, Solki S, Mozaffari S, Nikfar S, Abdollahi M. A systematic review of the safety of probiotics. Expert Opin Drug Saf. 2014;13:227-39. https://doi.org/10.1517/14740338.2014.872627
24. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr. 1995;125:1401-12. https://doi.org/10.1093/jn/125.6.1401
25. Markowiak P, Śliżewska K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients. 2017;9(pii):E1021. https://doi.org/10.3390/nu9091021
26. Food and Drug Administration. Investigational new drug applications (IND) — Determining whether human research studies can be conducted without an IND. Bethesda: Food and Drug Administration; 2013.
27. Hojsak I, Fabiano V, Pop TL, Goulet O, Zuccotti GV, Çokuğraş FC, et al. Guidance on the use of probiotics in clinical practice in children with selected clinical conditions and in specific vulnerable groups. Acta Paediatr. 2018;107:927-37. https://doi.org/10.1111/apa.14270
Cómo citar
1.
Gómez A. Microbioma, salud y enfermedad: probióticos, prebióticos y simbióticos. biomedica [Internet]. 1 de diciembre de 2019 [citado 25 de abril de 2024];39(4):617-21. Disponible en: https://revistabiomedica.org/index.php/biomedica/article/view/5308
Algunos artículos similares:
- Juan Pablo García, Julián Andrés Hoyos, John Alexander Alzate, Edilberto Cristancho, Bacteriemia tras la administración de Bacillus clausii para el tratamiento de la diarrea aguda: reporte de un caso , Biomédica: Vol. 41 Núm. Sp. 2 (2021): Octubre, Infecciones bacterianas y virales
Publicado
2019-12-01
Número
Sección
Editorial
Métricas
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | |
| Vistas de PDF | |
| Descargas de PDF | |
| Vistas de HTML | |
| Otras vistas | |
